Nat. Rev. Drug Discov. 20, 247–250 (2021). CAS PubMed Google Scholar Schwach, J., Abdellatif, M. & Stengl, A. More than toxins — current prospects in designing the next generation of antibody drug conjugates. Front. Biosci. 27, 240 (2022). CAS Google Scholar Maneiro, M. A...
[4] Nikolaos Diamantis and Udai Banerji. Antibody-drug conjugates—an emerging classof cancer treatment.British Journal of Cancer (2016) 114,362–367. [5] AlainBeck, Liliane Goetsch, Charles Dumontet and Nathalie Corvaïa.Strat...
抗体药物偶联物(Antibody-drug conjugate, ADC)是通过化学键将具有生物活性的细胞毒药物连接到单克隆抗体(mAb)上,单克隆抗体(mAb)作为载体将细胞毒药物靶向运输到目标细胞中发挥作用的一类药物。 2. 特点 抗体药物偶联物(Antibody-drug conjugate, ADC)既具有细胞毒药物杀伤力强大的特点,又结合了重组单克隆抗体(mAb)...
Advances in antibody have enabled identification and generation of humanized or human antibodies with high-affinity, highly-selectivity for a target of interest. Today, the knowledge of disease biology and engineering antibodies with ideal properties become the foundation of our ADC. We have adopted a...
Antibody-Drug Conjugate (ADC) 抗体偶联药物作为一种新型的抗癌药物,从 1959 年第一种抗体偶联药物报道以来,到目前为止,已经有三种 ADC 药物批准上市,60 多种 ADC 药物处于临床阶段。今天,我们请来了小 M 博士给大家讲讲 ADC~ ADC 抗体偶联药物作用机理 ...
internalized more readily by cancer cells.139Besides, more potent payloads such as PBD, tubulysin, and immunomodulator with novel mechanisms, have been developed to conjugate with antibodies.26Although the linkers types in the third generation did not show any updates, some novel entities such as ...
4. “Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy” Expert Opin. Biol. Ther., 2020, 20:8, 871. $吉利德科学(GILD)$$阿斯利康(AZN)$$科伦药业(SZ002422)$ @黄建平@张小丰@青侨阳光@空之客@汤诗语@秦汉相对论@董翔...
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant Pancreatic cancer. Br J Cancer. 2020;123:1502–12. 35. Zhu M, Zhou L, Hu S, Miao Q, Gong J, Zhang N, et al. Rational design ...
抗体药物偶联物(Antibody-drug conjugate, ADC)是通过化学键将具有生物活性的细胞毒药物连接到单克隆抗体(mAb)上,单克隆抗体(mAb)作为载体将细胞毒药物靶向运输到目标细胞中发挥作用的一类药物。 2. 特点 抗体药物偶联物(Antibody-drug conjugate, ADC)既具有细胞毒药物杀伤力强大的特点,又结合了重组单克隆抗体(mAb)...
Fig. 1 | Vincerx’s next-generation, modular antibody–drug conjugates for cancer. Vincerx has developed a customizable antibody–drug conjugate platform that allows for the modular combination of antibodies optimized for tumor selectivity and internalization, with (1) a legumain linker for improved ...